-
Biocon wins first FDA interchangeable label of Novolog biosimilar
18 Jul 2025 22:02 GMT
… . FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin …
-
Biocon, Dalmia Bharat among 10 stocks hitting new 52-week high; surge up to 25% in a month
18 Jul 2025 15:14 GMT
On Friday, the benchmark Sensex dropped by 501 points, closing at 81,757. However, even amid the broader market weakness, 10 stocks from the BSE 500 Index defied the trend by hitting their 52-week highs — reaching their highest levels in a year. Such …
-
Biocon among 11 stocks hitting 52-week high, rally up to 20% in a month
16 Jul 2025 20:18 GMT
… . Notable names among them include Biocon, HDFC Asset Management, and Nippon …
-
Breakout Stocks: How to trade Biocon, RBL Bank & HDFC AMC that hit fresh 52-week high?
16 Jul 2025 19:31 GMT
… , FMCG, realty, and IT sectors. Biocon, RBL Bank, and HDFC AMC … -week highs. Analysts suggest monitoring Biocon for a breakout above 425 …
-
FDA approves Biocon Biologics rapid-acting Insulin Kirsty
16 Jul 2025 18:08 GMT
… ;s biosimilars arm Biocon Biologics announced that the US … , CEO & MD, Biocon Biologics said.
Besides Biocon, in February this year …
-
Biocon eyes generic Wegovy launch in India, Canada in next 2 years, CEO says
16 Jul 2025 14:46 GMT
… [REUTER/YONHAP]
Biocon aims to launch generic copies … and Zepbound.
Biopharmaceutical company Biocon plans to submit a request … , he added.
"Biocon is actively progressing with filings …
In addition to Canada, Biocon will focus on large emerging …
-
Biocon eyes generic Wegovy obesity drug launch in India, Canada in next 2 years, CEO says
16 Jul 2025 10:58 GMT
… Sadam
HYDERABAD (Reuters) -Biocon aims to launch generic copies … and Zepbound.
Biopharmaceutical company Biocon plans to submit a … months, he added.
“Biocon is actively progressing with filings … In addition to Canada, Biocon will focus on large emerging …
-
Biocon Biologics expands biosimilar insulin portfolio with USFDA nod of Kirsty
16 Jul 2025 09:13 GMT
… company and subsidiary of Biocon Ltd., has received approval … approval of KIRSTY expands Biocon Biologics’ biosimilar insulin portfolio … CEO & Managing Director, Biocon Biologics Ltd., said, “The … 5.8M patients annually, Biocon Biologics has a comprehensive …
-
Biocon Biologics expands diabetes portfolio with US FDA approval of Kirsty, an interchangeable rapid-acting insulin aspart in US
16 Jul 2025 07:59 GMT
… company and subsidiary of Biocon announced that US FDA … FDA approval of Kirsty expands Biocon Biologics’ biosimilar insulin portfolio, … CEO & managing director, Biocon Biologics, said: “The FDA … .
The Bengaluru-based Biocon Biologics is a global leader …
-
Buy Biocon, Zydus Life For Short-Term Gains, Says SEBI RA Vinayak Gautam After Fresh Regulatory Approvals
16 Jul 2025 07:53 GMT
… on both pharma counters.
Biocon and Zydus Lifesciences are … and renewed retail interest.
Biocon shares rose 2% on Wednesday … on these two pharma counters:
Biocon
Biocon Biologics, its arm, secured … ‘bearish’ last week.
Biocon sentiment and message volume on …